Used as a key intermediate in pharmaceutical synthesis, particularly in Suzuki-Miyaura cross-coupling reactions to construct fluorinated pyridine derivatives. These compounds are valuable in the development of agrochemicals, medicinal agents, and functional materials due to the enhanced metabolic stability and bioavailability imparted by the fluoropyridine moiety. Its boronic acid group enables efficient carbon-carbon bond formation under mild conditions, making it suitable for late-stage functionalization in drug discovery. Commonly employed in the preparation of kinase inhibitors and other biologically active molecules where fluorine substitution improves target binding and pharmacokinetic properties.